why choose us

First received: October 16, 2023

Clinical Trial: TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Breast Cancer

Study Type: INTERVENTIONAL


Official Title: TACTIVE-U: AN INTERVENTIONAL SAFETY AND EFFICACY PHASE 1B/2, OPEN-LABEL UMBRELLA STUDY TO INVESTIGATE TOLERABILITY, PK, AND ANTITUMOR ACTIVITY OF VEPDEGESTRANT (ARV-471/PF-07850327), AN ORAL

Brief Summary: The purpose of this study is to learn about the safety and effects of the study medicine called vepdegestrant.The safety and effects of vepdegestrant will be see when given with other medicines.Vepdegestrant is studied to see if it can be a possible treatment for advanced metastatic breast cancer.This type of cancer would have spread from where it started (breast) to other parts of the body and would be tough to treat.The study is seeking for participants who have breast cancer that:is hard to treat (advanced) and…

Read more